Grandfield & Dodd’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.56M | Sell |
19,451
-40
| -0.2% | -$21.7K | 0.54% | 50 |
|
|
2025
Q4 | $11.3M | Buy |
19,491
+3
| +0% | +$1.7K | 0.64% | 47 |
|
|
2025
Q3 | $9.45M | Sell |
19,488
-198
| -1% | -$92.2K | 0.54% | 49 |
|
|
2025
Q2 | $7.98M | Buy |
19,686
+38
| +0.2% | +$15.9K | 0.47% | 50 |
|
|
2025
Q1 | $9.78M | Sell |
19,648
-80
| -0.4% | -$43.3K | 0.61% | 48 |
|
|
2024
Q4 | $10.3M | Sell |
19,728
-70
| -0.4% | -$38.5K | 0.63% | 49 |
|
|
2024
Q3 | $12.2M | Sell |
19,798
-370
| -2% | -$219K | 0.73% | 47 |
|
|
2024
Q2 | $11.2M | Sell |
20,168
-78
| -0.4% | -$44.7K | 0.71% | 47 |
|
|
2024
Q1 | $11.8M | Sell |
20,246
-4
| -0% | -$2.25K | 0.74% | 47 |
|
|
2023
Q4 | $10.7M | Sell |
20,250
-325
| -2% | -$157K | 0.74% | 47 |
|
|
2023
Q3 | $10.4M | Sell |
20,575
-258
| -1% | -$137K | 0.77% | 49 |
|
|
2023
Q2 | $10.9M | Sell |
20,833
-138
| -0.7% | -$74.5K | 0.76% | 48 |
|
|
2023
Q1 | $12.1M | Sell |
20,971
-442
| -2% | -$249K | 0.84% | 47 |
|
|
2022
Q4 | $11.8M | Sell |
21,413
-52
| -0.2% | -$27.6K | 0.86% | 45 |
|
|
2022
Q3 | $10.9M | Buy |
21,465
+600
| +3% | +$336K | 0.89% | 44 |
|
|
2022
Q2 | $11.3M | Sell |
20,865
-351
| -2% | -$193K | 0.89% | 47 |
|
|
2022
Q1 | $12.5M | Sell |
21,216
-811
| -4% | -$466K | 0.85% | 46 |
|
|
2021
Q4 | $14.7M | Sell |
22,027
-249
| -1% | -$155K | 0.95% | 44 |
|
|
2021
Q3 | $12.7M | Buy |
22,276
+350
| +2% | +$192K | 0.89% | 44 |
|
|
2021
Q2 | $11.1M | Sell |
21,926
-118
| -0.5% | -$55.7K | 0.77% | 46 |
|
|
2021
Q1 | $10.1M | Sell |
22,044
-212
| -1% | -$101K | 0.75% | 46 |
|
|
2020
Q4 | $10.4M | Sell |
22,256
-1,224
| -5% | -$574K | 0.81% | 44 |
|
|
2020
Q3 | $10.4M | Sell |
23,480
-793
| -3% | -$328K | 0.93% | 41 |
|
|
2020
Q2 | $8.8M | Sell |
24,273
-254
| -1% | -$85.1K | 0.85% | 45 |
|
|
2020
Q1 | $6.96M | Sell |
24,527
-66
| -0.3% | -$20.8K | 0.82% | 45 |
|
|
2019
Q4 | $7.99M | Sell |
24,593
-525
| -2% | -$159K | 0.73% | 48 |
|
|
2019
Q3 | $7.32M | Sell |
25,118
-500
| -2% | -$143K | 0.72% | 48 |
|
|
2019
Q2 | $7.52M | Sell |
25,618
-468
| -2% | -$129K | 0.74% | 48 |
|
|
2019
Q1 | $7.14M | Sell |
26,086
-310
| -1% | -$77.1K | 0.74% | 47 |
|
|
2018
Q4 | $5.91M | Sell |
26,396
-478
| -2% | -$112K | 0.7% | 49 |
|
|
2018
Q3 | $6.56M | Sell |
26,874
-655
| -2% | -$151K | 0.68% | 51 |
|
|
2018
Q2 | $5.7M | Sell |
27,529
-1,088
| -4% | -$231K | 0.63% | 52 |
|
|
2018
Q1 | $5.91M | Sell |
28,617
-1,084
| -4% | -$228K | 0.66% | 50 |
|
|
2017
Q4 | $5.64M | Sell |
29,701
-1,418
| -5% | -$272K | 0.6% | 50 |
|
|
2017
Q3 | $5.89M | Sell |
31,119
-740
| -2% | -$134K | 0.66% | 50 |
|
|
2017
Q2 | $5.56M | Sell |
31,859
-777
| -2% | -$131K | 0.66% | 48 |
|
|
2017
Q1 | $5.01M | Sell |
32,636
-1,395
| -4% | -$213K | 0.62% | 48 |
|
|
2016
Q4 | $4.8M | Sell |
34,031
-465
| -1% | -$68.6K | 0.62% | 46 |
|
|
2016
Q3 | $5.49M | Sell |
34,496
-400
| -1% | -$61.6K | 0.72% | 43 |
|
|
2016
Q2 | $5.16M | Sell |
34,896
-375
| -1% | -$55.3K | 0.72% | 44 |
|
|
2016
Q1 | $4.99M | Sell |
35,271
-137
| -0.4% | -$18.4K | 0.72% | 43 |
|
|
2015
Q4 | $5.02M | Sell |
35,408
-750
| -2% | -$100K | 0.76% | 45 |
|
|
2015
Q3 | $4.42M | Sell |
36,158
-100
| -0.3% | -$13K | 0.74% | 46 |
|
|
2015
Q2 | $4.71M | Sell |
36,258
-198
| -0.5% | -$25.8K | 0.72% | 47 |
|
|
2015
Q1 | $4.9M | Sell |
36,456
-970
| -3% | -$125K | 0.75% | 43 |
|
|
2014
Q4 | $4.69M | Sell |
37,426
-3,258
| -8% | -$396K | 0.72% | 43 |
|
|
2014
Q3 | $4.95M | Sell |
40,684
-490
| -1% | -$59.6K | 0.78% | 44 |
|
|
2014
Q2 | $4.86M | Buy |
41,174
+45
| +0.1% | +$5.3K | 0.73% | 47 |
|
|
2014
Q1 | $4.95M | Sell |
41,129
-1,000
| -2% | -$119K | 0.78% | 46 |
|
|
2013
Q4 | $4.69M | Sell |
42,129
-1,490
| -3% | -$148K | 0.76% | 47 |
|
|
2013
Q3 | $4.02M | Sell |
43,619
-545
| -1% | -$49.3K | 0.72% | 48 |
|
|
2013
Q2 | $3.74M | Buy |
+44,164
| New | +$3.68M | 0.71% | 47 |
|
Other funds holding TMO
VCM
Grandfield & Dodd's TMO Position: Q1 2026 in Review
Grandfield & Dodd reduced its Thermo Fisher Scientific (TMO) stake by 0.21% in Q1 2026, selling an estimated $21.7K and leaving 19,451 shares worth $9.56M. The position accounts for 0.54% of the portfolio, ranked #50.
Grandfield & Dodd first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.7M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Grandfield & Dodd held 19,451 shares of Thermo Fisher Scientific worth $9.56M as of Q1 2026.
- Grandfield & Dodd sold 40 Thermo Fisher Scientific shares in Q1 2026, an estimated $21.7K.
- Thermo Fisher Scientific made up 0.54% of Grandfield & Dodd's portfolio in Q1 2026, its #50 holding.
- Grandfield & Dodd first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Grandfield & Dodd's Thermo Fisher Scientific position peaked at $14.7M in Q4 2021.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Grandfield & Dodd's 13F filing for Q1 2026, filed 7 May 2026.